国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Natronomonas pharaonis Diphthine synthase (dphB) CSB-YP660452NAAJ
CSB-EP660452NAAJ
CSB-BP660452NAAJ
CSB-MP660452NAAJ
CSB-EP660452NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP660453NAAJ
CSB-EP660453NAAJ
CSB-BP660453NAAJ
CSB-MP660453NAAJ
CSB-EP660453NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis 30S ribosomal protein S6e (rps6e) CSB-YP660454NAAJ
CSB-EP660454NAAJ
CSB-BP660454NAAJ
CSB-MP660454NAAJ
CSB-EP660454NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Geranylgeranylglyceryl phosphate synthase (NP1224A) CSB-YP660455NAAJ
CSB-EP660455NAAJ
CSB-BP660455NAAJ
CSB-MP660455NAAJ
CSB-EP660455NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis ATP phosphoribosyltransferase (hisG) CSB-YP660456NAAJ
CSB-EP660456NAAJ
CSB-BP660456NAAJ
CSB-MP660456NAAJ
CSB-EP660456NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Replication factor C small subunit (rfcS) CSB-YP660457NAAJ
CSB-EP660457NAAJ
CSB-BP660457NAAJ
CSB-MP660457NAAJ
CSB-EP660457NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis UvrABC system protein B (uvrB), partial CSB-YP660458NAAJ
CSB-EP660458NAAJ
CSB-BP660458NAAJ
CSB-MP660458NAAJ
CSB-EP660458NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Probable lipoyl synthase (lipA) CSB-YP660459NAAJ
CSB-EP660459NAAJ
CSB-BP660459NAAJ
CSB-MP660459NAAJ
CSB-EP660459NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Dihydroorotate dehydrogenase (quinone) (pyrD) CSB-YP660460NAAJ
CSB-EP660460NAAJ
CSB-BP660460NAAJ
CSB-MP660460NAAJ
CSB-EP660460NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Valine--tRNA ligase (valS), partial CSB-YP660461NAAJ
CSB-EP660461NAAJ
CSB-BP660461NAAJ
CSB-MP660461NAAJ
CSB-EP660461NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Prefoldin subunit alpha (pfdA) CSB-YP660462NAAJ
CSB-EP660462NAAJ
CSB-BP660462NAAJ
CSB-MP660462NAAJ
CSB-EP660462NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Arginine--tRNA ligase (argS), partial CSB-YP660463NAAJ
CSB-EP660463NAAJ
CSB-BP660463NAAJ
CSB-MP660463NAAJ
CSB-EP660463NAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Probable 5-dehydro-4-deoxyglucarate dehydratase (RHOS4_36970) CSB-YP660464RLF
CSB-EP660464RLF
CSB-BP660464RLF
CSB-MP660464RLF
CSB-EP660464RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Zinc import ATP-binding protein ZnuC (znuC) CSB-YP660465RLF
CSB-EP660465RLF
CSB-BP660465RLF
CSB-MP660465RLF
CSB-EP660465RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Protein RnfH (rnfH) CSB-YP660466RLF
CSB-EP660466RLF
CSB-BP660466RLF
CSB-MP660466RLF
CSB-EP660466RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Dihydroxy-acid dehydratase (ilvD), partial CSB-YP660467RLF
CSB-EP660467RLF
CSB-BP660467RLF
CSB-MP660467RLF
CSB-EP660467RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides 50S ribosomal protein L36 (rpmJ) CSB-YP660468RLF
CSB-EP660468RLF
CSB-BP660468RLF
CSB-MP660468RLF
CSB-EP660468RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) CSB-YP660469RLF
CSB-EP660469RLF
CSB-BP660469RLF
CSB-MP660469RLF
CSB-EP660469RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Dephospho-CoA kinase (coaE) CSB-YP660470RLF
CSB-EP660470RLF
CSB-BP660470RLF
CSB-MP660470RLF
CSB-EP660470RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Argininosuccinate synthase (argG) CSB-YP660471RLF
CSB-EP660471RLF
CSB-BP660471RLF
CSB-MP660471RLF
CSB-EP660471RLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>